1. A recombinant vaccinia virus containing the papilloma E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity

   • Carlos Rosales
   • Viviana Valadez Graham
   • Ricardo Rosales

   ORIGINAL ARTICLE Pages: 347 - 360

2. Local injections of OK432 can help the infiltration of adoptively transferred CD8⁺ T cells into the tumor sites and synergistically induce the local production of Th1-type cytokines and CXC3 chemokines

   • Katsunori Tatsugami
   • Koji Tamada
   • Kikuo Nomoto

   ORIGINAL ARTICLE Pages: 361 - 368

3. Killing of Fas ligand-resistant renal carcinoma cells by interleukin-2- and BCG-activated effector cells

   • Sven Brandau
   • Henrik Suttmann
   • Andreas Böhle

   ORIGINAL ARTICLE Pages: 369 - 376

4. Soluble Fas/Apo-1 (CD95) levels during T cell activation in the presence of acute myelogenous leukemia accessory cells; contributions from local release and variations in systemic levels

   • Øystein Bruserud
   • Elling Ulvestad

   ORIGINAL ARTICLE Pages: 377 - 387

5. Simultaneous measurement of soluble carcinoembryonic antigen and the tissue inhibitor of metalloproteinase TIMP1 serum levels for use as markers of pre-invasive to invasive colorectal cancer

   • Patrizia Pellegrini
   • Ida Contasta
   • Domenico Adorno

   ORIGINAL ARTICLE Pages: 388 - 394

6. Sequential administration of interferon γ and interleukin-2 in metastatic renal cell carcinoma: results of a phase II trial

   • Manuela Schmidinger
   • Günther G. Steger
   • for the Austrian Renal Cell Carcinoma Study Group

   ORIGINAL ARTICLE Pages: 395 - 400